Literature DB >> 2549544

Surface immunoglobulin-mediated B-cell activation in the absence of detectable elevations in intracellular ionized calcium: a model for T-cell-independent B-cell activation.

M Brunswick1, C H June, F D Finkelman, H M Dintzis, J K Inman, J J Mond.   

Abstract

We recently showed that anti-immunoglobulin conjugated to high molecular weight dextran is 1000-fold more mitogenic for B cells than unconjugated anti-immunoglobulin. This system serves as a model for T-cell-independent type 2 antigens such as haptenated Ficoll, dextran, and bacterial polysaccharides, which can also stimulate B-cell proliferation and antibody production at low concentrations. We show here that conjugated anti-immunoglobulin, at concentrations that stimulate significant increases in expression of major histocompatibility complex class II molecules and incorporation of thymidine into DNA, does not induce detectable modulation of surface immunoglobulin. These results indicate that the facilitated T-cell-independent B-cell activation by polysaccharide antigens may result from inability to modulate surface immunoglobulin, possibly resulting in persistent and/or repetitive signaling. Early large increases in Ca2+ and breakdown of inositol phospholipids presently thought to be involved in transduction of the mitogenic signal are not detectable at low concentrations of conjugated anti-immunoglobulin, raising the possibility that these biochemical events may not in fact be central to this signaling pathway.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2549544      PMCID: PMC297918          DOI: 10.1073/pnas.86.17.6724

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Relationship between enhanced turnover of phosphatidylinositol and lymphocyte activation by mitogens.

Authors:  V C Maino; M J Hayman; M J Crumpton
Journal:  Biochem J       Date:  1975-01       Impact factor: 3.857

Review 2.  Inositol trisphosphate and diacylglycerol as second messengers.

Authors:  M J Berridge
Journal:  Biochem J       Date:  1984-06-01       Impact factor: 3.857

3.  Increased phosphatidylinositol metabolism is an important but not an obligatory early event in B lymphocyte activation.

Authors:  S A Grupp; J A Harmony
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

4.  In vitro and in vivo B lymphocyte-activating properties of monoclonal anti-delta antibodies. I. Determinants of B lymphocyte-activating properties.

Authors:  D K Goroff; A Stall; J J Mond; F D Finkelman
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

5.  Molecular events in B cell activation. I. Signals required to stimulate G0 to G1 transition of resting B lymphocytes.

Authors:  J G Monroe; M J Kass
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

6.  B cell activation. VIII. Membrane immunoglobulins transduce signals via activation of phosphatidylinositol hydrolysis.

Authors:  K M Coggeshall; J C Cambier
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

7.  B cell activation. IV. Induction of cell membrane depolarization and hyper-I-A expression by phorbol diesters suggests a role for protein kinase C in murine B lymphocyte activation.

Authors:  J G Monroe; J E Niedel; J C Cambier
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

8.  T cell receptor-mediated signaling occurs in the absence of inositol phosphate production.

Authors:  A M O'Rourke; M F Mescher
Journal:  J Biol Chem       Date:  1988-12-15       Impact factor: 5.157

9.  Phorbol ester and sperm activate mouse oocytes by inducing sustained oscillations in cell Ca2+.

Authors:  K S Cuthbertson; P H Cobbold
Journal:  Nature       Date:  1985 Aug 8-14       Impact factor: 49.962

10.  Crosslinking of surface immunoglobulin and Fc receptors on B lymphocytes inhibits stimulation of inositol phospholipid breakdown via the antigen receptors.

Authors:  M K Bijsterbosch; G G Klaus
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

View more
  8 in total

1.  Increase in the intracellular free calcium concentration is not an obligatory early event in lipopeptide-induced B-cell activation.

Authors:  S Hauschildt; A Lückhoff; J Langhorne; K H Wiesmüller; G Jung; W Bessler; J C Cambier
Journal:  Immunology       Date:  1991-07       Impact factor: 7.397

2.  Relationships between the degree of cross-linking of surface immunoglobulin and the associated inositol 1,4,5-trisphosphate and Ca2+ signals in human B cells.

Authors:  F M McConnell; S B Shears; P J Lane; M S Scheibel; E A Clark
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

3.  Ia-antigen-T-cell interactions for a thymus-independent antigen composed of D amino acids.

Authors:  E Zisman; M Dayan; M Sela; E Mozes
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

Review 4.  Human innate B cells: a link between host defense and autoimmunity?

Authors:  Eric C B Milner; Jennifer Anolik; Amedeo Cappione; Iñaki Sanz
Journal:  Springer Semin Immunopathol       Date:  2005-01-05

5.  A simplified method for Ca2+ flux measurement on isolated human B cells that uses flow cytometry.

Authors:  L Gergely; L Cook; V Agnello
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

6.  Surface immunoglobulin crosslinking activates a tyrosine kinase pathway in B cells that is independent of protein kinase C.

Authors:  M Brunswick; L E Samelson; J J Mond
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

7.  Health effects of the war in two rural communities in Nicaragua. Nicaragua Health Study Collaborative at Harvard, CIES, and UNAN.

Authors: 
Journal:  Am J Public Health       Date:  1989-04       Impact factor: 9.308

8.  Persistent calcium elevation correlates with the induction of surface immunoglobulin-mediated B cell DNA synthesis.

Authors:  H Yamada; C H June; F Finkelman; M Brunswick; M S Ring; A Lees; J J Mond
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.